CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Etodolac

依托度酸 杂质对照品Etodolac Impurities

EP32 个杂质条目32 impurity entries

本页汇总 依托度酸 的 32 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Etodolac with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 依托度酸(Etodolac)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDetermination of enantiomeric impurity of etodolac by capillary electrophoresis using (2-hydroxypropyl)-beta-cyclodextrin
    Archives of pharmacal research · 2008 · Dung PT et al.  ·  PMID 18806967  ·  DOI
  2. 杂质研究Impurity studiesPhotochemical fate and eco-genotoxicity assessment of the drug etodolac
    The Science of the total environment · 2015 · Passananti M et al.  ·  PMID 25765378  ·  DOI
  3. 杂质研究Impurity studiesImprovement of the etodolac purity test by reversed phase high-performance liquid chromatography
    Die Pharmazie · 2008 · Ammar A, Surmann P  ·  PMID 19177910
  4. 分析方法Analytical MethodsLiquid chromatographic methods for separation, determination, and bioassay of enantiomers of etodolac: A review
    Journal of separation science · 2020 · Singh M et al.  ·  PMID 31389172  ·  DOI
  5. 分析方法Analytical MethodsOptimization and validation of an HPLC method for the quantification of Etodolac in liposomes and assessment of its pharmacokinetic profile
    Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2026 · Wais FMH, Al-Edresi S  ·  PMID 41759005  ·  DOI

依托度酸 —— 原料药与杂质对照品Etodolac — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Etodolac Impurity 1 (Etodolac EP Impurity A) structure
EPA
依托度酸杂质1(依托度酸EP杂质A)Etodolac Impurity 1 (Etodolac EP Impurity A)
Etodolac Impurity 1 (Etodolac EP Impurity A)
CAS No.41339-67-7
Chemical FormulaC15H17NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 2 (Etodolac EP Impurity B) structure
EPB
依托度酸杂质2(依托度酸EP杂质B)Etodolac Impurity 2 (Etodolac EP Impurity B)
Etodolac Impurity 2 (Etodolac EP Impurity B)
CAS No.41340-19-6
Chemical FormulaC16H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 3 (Etodolac EP Impurity C) structure
EPC
依托度酸杂质3(依托度酸EP杂质C)Etodolac Impurity 3 (Etodolac EP Impurity C)
Etodolac Impurity 3 (Etodolac EP Impurity C)
CAS No.109518-47-0
Chemical FormulaC16H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 4 (Etodolac EP Impurity D) structure
EPD
依托度酸杂质4 (依托度酸EP杂质D)Etodolac Impurity 4 (Etodolac EP Impurity D)
Etodolac Impurity 4 (Etodolac EP Impurity D)
CAS No.57917-63-2
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 5 (Etodolac EP Impurity E) structure
EPE
依托度酸杂质5(依托度酸EP杂质E)Etodolac Impurity 5 (Etodolac EP Impurity E)
Etodolac Impurity 5 (Etodolac EP Impurity E)
CAS No.57817-27-3
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 6 (Etodolac EP Impurity F) structure
EPF
依托度酸杂质6(依托度酸EP杂质F)Etodolac Impurity 6 (Etodolac EP Impurity F)
Etodolac Impurity 6 (Etodolac EP Impurity F)
CAS No.849630-65-5
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 7 (Etodolac EP Impurity G) structure
EPG
依托度酸杂质7(依托度酸EP杂质G)Etodolac Impurity 7 (Etodolac EP Impurity G)
Etodolac Impurity 7 (Etodolac EP Impurity G)
CAS No.57816-83-8
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 8 (Etodolac EP Impurity H) structure
EPH
依托度酸杂质8(依托度酸EP杂质H)Etodolac Impurity 8 (Etodolac EP Impurity H)
Etodolac Impurity 8 (Etodolac EP Impurity H)
CAS No.41340-36-7
Chemical FormulaC12H15NO
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 10 (Etodolac EP Impurity J) (Decarboxy Etodolac) structure
EPJ
依托度酸杂质10 (依托度酸EP杂质J) (脱羧依托度酸)Etodolac Impurity 10 (Etodolac EP Impurity J) (Decarboxy Etodolac)
Etodolac Impurity 10 (Etodolac EP Impurity J) (Decarboxy Etodolac)
CAS No.115066-03-0
Chemical FormulaC16H21NO
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 11 (Etodolac EP Impurity K) structure
EPK
依托度酸杂质11(依托度酸EP杂质K)Etodolac Impurity 11 (Etodolac EP Impurity K)
Etodolac Impurity 11 (Etodolac EP Impurity K)
CAS No.122188-02-7
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 1 structure
1
依托度酸杂质33Etodolac Impurity 1
Etodolac Impurity 1
CAS No.101901-08-0
Chemical FormulaC17H21NO4
Purity>95%现货In stock
10mg25mg50mg100mg
Etodolac Impurity 2 structure
2
依托度酸杂质24 (6-羟基依托度酸)Etodolac Impurity 2
Etodolac Impurity 2
CAS No.101901-06-8
Chemical FormulaC17H21NO4
Purity>95%现货In stock
10mg25mg50mg100mg
Etodolac Impurity 3 structure
3
依托度酸杂质3Etodolac Impurity 3
Etodolac Impurity 3
CAS No.101901-07-9
Chemical FormulaC17H21NO4
Purity>95%现货In stock
10mg25mg50mg100mg
Etodolac Impurity 14 ((R)-(-)-Etodolac) structure
14
依托度酸杂质14 ((R)-(-)-依托度酸)Etodolac Impurity 14 ((R)-(-)-Etodolac)
Etodolac Impurity 14 ((R)-(-)-Etodolac)
CAS No.87226-41-3
Chemical FormulaC17H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 15 ((S)-(+)-Etodolac) structure
15
依托度酸杂质15 ((S-(+)-依托度酸)Etodolac Impurity 15 ((S)-(+)-Etodolac)
Etodolac Impurity 15 ((S)-(+)-Etodolac)
CAS No.87249-11-4
Chemical FormulaC17H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 16 (rac Etodolac Acyl-β-D-glucuronide) structure
16
依托度酸杂质16 (依托度酸-β-D-葡糖苷酸)Etodolac Impurity 16 (rac Etodolac Acyl-β-D-glucuronide)
Etodolac Impurity 16 (rac Etodolac Acyl-β-D-glucuronide)
CAS No.79541-43-8
Chemical FormulaC23H29NO9
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 17 structure
17
依托度酸杂质17Etodolac Impurity 17
Etodolac Impurity 17
CAS No.111478-84-3
Chemical FormulaC18H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 18 structure
18
依托度酸杂质18Etodolac Impurity 18
Etodolac Impurity 18
CAS No.114720-21-7
Chemical FormulaC18H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 20 structure
20
依托度酸杂质20Etodolac Impurity 20
Etodolac Impurity 20
CAS No.849630-33-7
Chemical FormulaC18H25NO2
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 21 structure
21
依托度酸杂质21Etodolac Impurity 21
Etodolac Impurity 21
CAS No.114737-75-6
Chemical FormulaC12H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 22 structure
22
依托度酸杂质22Etodolac Impurity 22
Etodolac Impurity 22
CAS No.849630-60-0
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 25 (N-Methyl Etodolac) structure
25
依托度酸杂质25 (N-甲基 依托度酸)Etodolac Impurity 25 (N-Methyl Etodolac)
Etodolac Impurity 25 (N-Methyl Etodolac)
CAS No.849630-94-0
Chemical FormulaC18H23NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 26 (4-Oxo Etodolac) structure
26
依托度酸杂质26 (4-Oxo依托度酸)Etodolac Impurity 26 (4-Oxo Etodolac)
Etodolac Impurity 26 (4-Oxo Etodolac)
CAS No.111478-86-5
Chemical FormulaC17H19NO4
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 27 structure
27
依托度酸杂质27Etodolac Impurity 27
Etodolac Impurity 27
CAS No.111962-14-2
Chemical FormulaC17H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 31 structure
31
依托度酸杂质31Etodolac Impurity 31
Etodolac Impurity 31
CAS No.630396-56-4
Chemical FormulaC14H14ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 32 structure
32
依托度酸杂质32Etodolac Impurity 32
Etodolac Impurity 32
CAS No.314734-19-5
Chemical FormulaC17H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 34 structure
34
依托度酸杂质34Etodolac Impurity 34
Etodolac Impurity 34
CAS No.109518-50-5
Chemical FormulaC16H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 37 (N-Nitroso Indole) structure
37
依托度酸杂质37 (N-亚硝基吲哚)Etodolac Impurity 37 (N-Nitroso Indole)
Etodolac Impurity 37 (N-Nitroso Indole)
CAS No.117782-96-4
Chemical FormulaC8H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 45 structure
45
依托度酸杂质45Etodolac Impurity 45
Etodolac Impurity 45
CAS No.526-55-6
Chemical FormulaC10H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 46 (N-Nitroso Etodolac Impurity 45) structure
46
依托度酸杂质46 (N-亚硝基依托度酸杂质45)Etodolac Impurity 46 (N-Nitroso Etodolac Impurity 45)
Etodolac Impurity 46 (N-Nitroso Etodolac Impurity 45)
CAS No.120314-14-9
Chemical FormulaC10H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 48 structure
48
依托度酸杂质48Etodolac Impurity 48
Etodolac Impurity 48
CAS No.2769150-68-5
Chemical FormulaC22H29NO3
Purity>95%询价On request
10mg25mg50mg100mg
Etodolac Impurity 49 structure
49
依托度酸杂质49Etodolac Impurity 49
Etodolac Impurity 49
CAS No.118313-81-8
Chemical FormulaC18H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

依托度酸 —— 研究文献与合成路线Etodolac — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 依托度酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Etodolac. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Determination of enantiomeric impurity of etodolac by capillary electrophoresis using (2-hydroxypropyl)-beta-cyclodextrin
    Dung PT, Ko MY, Choi HJ, et al. · Archives of pharmacal research · 2008 · 被引 8cited 8
  2. Comparative photo-oxidative degradation of etodolac, febuxostat and imatinib mesylate by UV-C/H2O2 and UV-C/S2O82- processes: Modeling, treatment optimization and biodegradability enhancement
    Samzadeh A, Dehghani M, Baghapour MA, et al. · Environmental research · 2022
  3. Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations
    el-Hay SS, Colyer CL, Hassan WS, et al. · Journal of fluorescence · 2012 · 被引 2cited 2
  4. Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations
    Gouda AA, Hassan WS · Chemistry Central journal · 2008 · 被引 1cited 1
  5. In-vivo gamma scintigraphic evaluation and determination of a gastro-resistant etodolac tablet in humans
    Ozkan Y, Ceyhan T, Arslan N, et al. · Combinatorial chemistry & high throughput screening · 2010

合成与制备工艺专利Synthesis & process patents

  1. Preparation method for etodolac
    LIANBO ZHU, CHONG WANG, CHUANQING HUANGFU · 公开号 CN101085778CN101085778 · 2007
  2. Tape preparation comprising etodolac in ionic liquid form
    MIWA YASUSHI, HAMAMOTO HIDETOSHI · 公开号 AU2008334222AU2008334222 · 2009
  3. TAPE PREPARATION COMPRISING ETODOLAC IN IONIC LIQUID FORM
    HAMAMOTO HIDETOSHI, MIWA YASUSHI · 公开号 US2010280090US2010280090 · 2010
  4. TAPE PREPARATION COMPRISING ETODOLAC IN IONIC LIQUID FORM
    HAMAMOTO HIDETOSHI, MIWA YASUJI · 公开号 WO2009075094WO2009075094 · 2009
  5. TAPE PREPARATION COMPRISING ETODOLAC IN IONIC LIQUID FORM
    HAMAMOTO HIDETOSHI, MIWA YASUSHI · 公开号 EP2233138EP2233138 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

依托度酸 杂质谱研究要点Etodolac — impurity profiling notes

下面这些是拿到 依托度酸 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Etodolac, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances